Markets

Earnings Season Watch List: MiMedx

Shutterstock photo

IBD 50 and Sector Leaders member MiMedx ( MDXG ) is expected to report earnings on Feb. 23. MiMedx now trading 6% below the 17.57 buy point from a first-stage cup without handle that it cleared earlier.

[ibd-display-video id=2360792 width=50 float=left autostart=true] Keep in mind that it's risky to buy any stock just before it reports. You can reduce your exposure by waiting to see the actual numbers and the market's reaction.

See How IBD Helps You Make More Money In Stocks

MiMedx showed 33% EPS growth in its most recent report, while sales growth came in at 31%.

Analysts are looking for EPS growth of 42% for the quarter, and 45% growth for the full year. Annual growth estimates were recently revised lower.

MiMedx has a 97 Composite Rating and earns the No. 3 rank among its peers in the Medical-Products industry group. Align Technology ( ALGN ) is the top-ranked stock within the group.

Note: Dates for earnings reports are subject to change. Check the company's website for any updates.

RELATED:

Earnings Calendar, Analyst Estimates And Stocks To Watch

New Option Strategy Limits Risk Around Earnings

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MDXG ALGN

Other Topics

Stocks

Latest Markets Videos